Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Two major clinical trials support safety and efficacy of TOBI in cystic fibrosis patients

Jan. 11, 1999

Magainin and Genentech enter collaboration for asthma treatment

Jan. 11, 1999

New LTB4 receptor antagonists disclosed by Boehringer Ingelheim

Dec. 30, 1998

Anti-IL-5R monoclonal antibodies and antagonists in development by Tanox

Dec. 29, 1998

Improvement in ischemia-reperfusion lung injury by treatment with FR-167653

Dec. 28, 1998

Japanese approval sought for Accolate

Dec. 23, 1998

PathoGenesis reports encouraging phase II results for TOBI in bronchiectasis

Dec. 23, 1998

Pharmacological profile of dual LTD4/TxA2 receptor antagonist YM-158

Dec. 21, 1998

HMR patents new series of tachykinin receptor antagonists for asthma, cough and bronchitis

Dec. 18, 1998

Leukotriene biosynthesis inhibitors described by Ortho-McNeil for inflammatory disorders

Dec. 18, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...